Thromboinflammatory Biomarkers in COVID-19: Systematic Review and Meta-analysis of 17,052 Patients
Research article
Published on
Journal: Mayo Clinic Proceedings: Innovations, Quality & Outcomes [Category] 바이오마커, 유전자 메커니즘,
Journal: Mayo Clinic Proceedings: Innovations, Quality & Outcomes [Category] 바이오마커, 유전자 메커니즘,
[키워드] 95% CI
Biomarker
biomarkers of inflammation
C-reactive protein
C-reactive protein (CRP
Cerebrovascular disease
Chronic kidney disease
chronic obstructive
CINAHL
Controlled
Coronavirus disease 2019
COVID-19
COVID-19 infection
COVID-19 severity
COVID-19coronavirus disease 2019
criteria
CRP
CRPC-reactive protein
D-dimer
database
death
diabetes
disease
disease severity
ECMOextracorporeal membrane oxygenation
end-organ damage
evaluate
extracorporeal membrane oxygenation
ferritin
fibrinogen
greater
group
heterogeneity
high-sensitivity
hospitalized patient
hshigh-sensitivity
hypertension
IL-6interleukin 6
inferences
interleukin 6
lactate dehydrogenase
LDHlactate dehydrogenase
malignancy
marker
mean difference
men
mild infection
Mortality
objective
Odds ratio
Older
OROdds Ratio
parameter
Patient
patients
Prevalence
proportion
pulmonary disease
random-effects model
Result
review
searched
severe coronavirus disease
severe COVID-19 disease
severe disease
severity
significantly higher
survivor
thrombosis
troponin I
was used
Web of Science
weighted mean difference
WMDweighted mean difference
[DOI] 10.1016/j.mayocpiqo.2021.01.009 [Article Type] Research article
[DOI] 10.1016/j.mayocpiqo.2021.01.009 [Article Type] Research article